[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.Read more
We are so thrilled to be back on the road and to attend upcoming in-person & digital meetings. Please check our forthcoming ones and do not hesitate to contact us to schedule a meeting
We are thrilled to actively participate to this must-be event to get to know all the upcoming trends in Pharma to speed and secure drug discovery and development for patients’ benefits.
[TALK] StéphaneGerart, Head of Artificial Intelligence Business Unit, is speaking in stream “ML and AI based Drug Discovery”
📢 Precision Medicine powered by AI: therapeutic target selection (identification / validation)
📅 10th May
👁️Have a glance at the program
👇 Do not forget to use 10% discount code for your registration ONCO10
European partnering convention entirely dedicated to open innovation in oncology | A two-day partnering convention combining conferences, collaborative sessions, projects’ pitches, one-to-one prescheduled business meetings as well as an exhibition area.
Stéphane Gerart will attend this event to propose our brand new integrated IA solution to identify & select the best potential target for your drug success. If you are looking for a techno-scientific company to initiate partnerships for very early drug discovery phase, contact us.
Watch our video to discover our AI Business Unit
“1st IA Health meetings in Dijon” ; Two days to have 1/a state of the art and exchange on the role of AI in Health and 2/know the projects involving AI in Health.
📅 20 May 2022 | 10.30 am
📍Campus @ESEO | Dijon
📢Stéphane Gerart will speak to explain the contributions of AI in the Drug Discovery process and the possible opportunities for precision medicine.
Réseau SATT, Cancéropôle Est s’associent pour un évènement exceptionnel pour détecter et promouvoir le développement et le transfert de projets innovants.